# Associated Banc-Corp: financial statements, quarterly

ASB · NYSE · CIK 7789 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asb.md) · [Financials](/companies/asb/financials.md) · [Filings](/companies/asb/filings.md) · [Insiders](/companies/asb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/asb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [122 d](/filings/0000007789-24-000009.md) | [323](/filings/0000007789-24-000043.md) | [322](/filings/0000007789-24-000062.md) | [330](/filings/0000007789-24-000075.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [272 d](/filings/0000007789-26-000071.md) | [266](/filings/0000007789-25-000049.md) | [274](/filings/0000007789-25-000116.md) | [278](/filings/0000007789-25-000179.md) | [258 d](/filings/0000007789-26-000071.md) | [240](/filings/0000007789-26-000141.md) | [246](/filings/0000007789-26-000202.md) | [251](/filings/0000007789-26-000260.md) | [234 d](/filings/0000007789-26-000071.md) | [221](/filings/0000007789-26-000141.md) | [253](/filings/0000007789-26-000202.md) | [256](/filings/0000007789-26-000260.md) |
| Income tax | $m | [(47.2) d](/filings/0000007789-26-000071.md) | [20.0](/filings/0000007789-25-000049.md) | [(12.7)](/filings/0000007789-25-000116.md) | [20.1](/filings/0000007789-25-000179.md) | [(16.1) d](/filings/0000007789-26-000071.md) | [19.4](/filings/0000007789-26-000141.md) | [28.4](/filings/0000007789-26-000202.md) | [29.6](/filings/0000007789-26-000260.md) | [25.8 d](/filings/0000007789-26-000071.md) | [33.2](/filings/0000007789-26-000141.md) | [35.6](/filings/0000007789-26-000202.md) | [43.4](/filings/0000007789-26-000260.md) |
| Net income | $m | [(90.8) d](/filings/0000007789-26-000071.md) | [81.2](/filings/0000007789-25-000179.md) | [116](/filings/0000007789-25-000179.md) | [88.0](/filings/0000007789-25-000179.md) | [(162) d](/filings/0000007789-26-000071.md) | [102](/filings/0000007789-26-000260.md) | [111](/filings/0000007789-26-000260.md) | [125](/filings/0000007789-26-000260.md) | [137 d](/filings/0000007789-26-000071.md) | [120](/filings/0000007789-26-000260.md) | [124](/filings/0000007789-26-000260.md) | [147](/filings/0000007789-26-000260.md) |
| Diluted EPS | $ per share | not reported | [0.52](/filings/0000007789-25-000049.md) | [0.74](/filings/0000007789-25-000116.md) | [0.56](/filings/0000007789-25-000179.md) | not reported | [0.59](/filings/0000007789-26-000141.md) | [0.65](/filings/0000007789-26-000202.md) | [0.73](/filings/0000007789-26-000260.md) | not reported | [0.70](/filings/0000007789-26-000141.md) | [0.63](/filings/0000007789-26-000202.md) | [0.76](/filings/0000007789-26-000260.md) |
| Basic EPS | $ per share | not reported | [0.52](/filings/0000007789-25-000049.md) | [0.75](/filings/0000007789-25-000116.md) | [0.56](/filings/0000007789-25-000179.md) | not reported | [0.60](/filings/0000007789-26-000141.md) | [0.65](/filings/0000007789-26-000202.md) | [0.73](/filings/0000007789-26-000260.md) | not reported | [0.70](/filings/0000007789-26-000141.md) | [0.64](/filings/0000007789-26-000202.md) | [0.77](/filings/0000007789-26-000260.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [41.0](/filings/0000007789-25-000013.md) | [41.1](/filings/0000007789-24-000043.md) | [41.6](/filings/0000007789-24-000062.md) | [42.2](/filings/0000007789-24-000075.md) | [43.0](/filings/0000007789-26-000071.md) | [43.3](/filings/0000007789-25-000049.md) | [44.0](/filings/0000007789-25-000116.md) | [44.5](/filings/0000007789-25-000179.md) | [45.2](/filings/0000007789-26-000260.md) | [45.6](/filings/0000007789-26-000141.md) | [51.8](/filings/0000007789-26-000202.md) | [51.4](/filings/0000007789-26-000260.md) |
| Total liabilities | $bn | [36.8](/filings/0000007789-25-000013.md) | [37.0](/filings/0000007789-24-000043.md) | [37.4](/filings/0000007789-24-000062.md) | [37.8](/filings/0000007789-24-000075.md) | [38.4](/filings/0000007789-26-000071.md) | [38.6](/filings/0000007789-25-000049.md) | [39.2](/filings/0000007789-25-000116.md) | [39.6](/filings/0000007789-25-000179.md) | [40.2](/filings/0000007789-26-000260.md) | [40.6](/filings/0000007789-26-000141.md) | [46.2](/filings/0000007789-26-000202.md) | [45.9](/filings/0000007789-26-000260.md) |
| Long-term debt | $bn | [0.5](/filings/0000007789-24-000075.md) | [0.5](/filings/0000007789-24-000043.md) | [0.5](/filings/0000007789-24-000062.md) | [0.8](/filings/0000007789-24-000075.md) | [0.8](/filings/0000007789-25-000179.md) | [0.6](/filings/0000007789-25-000049.md) | [0.6](/filings/0000007789-25-000116.md) | [0.6](/filings/0000007789-25-000179.md) | [0.6](/filings/0000007789-26-000260.md) | [0.6](/filings/0000007789-26-000141.md) | [0.6](/filings/0000007789-26-000202.md) | [0.6](/filings/0000007789-26-000260.md) |
| Short-term borrowings | $bn | [0.3](/filings/0000007789-24-000075.md) | [0.8](/filings/0000007789-24-000043.md) | [0.9](/filings/0000007789-24-000062.md) | [0.9](/filings/0000007789-24-000075.md) | [0.5](/filings/0000007789-26-000071.md) | [0.3](/filings/0000007789-25-000049.md) | [0.1](/filings/0000007789-25-000116.md) | [0.4](/filings/0000007789-25-000179.md) | [0.3](/filings/0000007789-26-000260.md) | [0.4](/filings/0000007789-26-000141.md) | [0.5](/filings/0000007789-26-000202.md) | [0.3](/filings/0000007789-26-000260.md) |
| Shareholders' equity | $bn | [4.2](/filings/0000007789-26-000071.md) | [4.2](/filings/0000007789-25-000179.md) | [4.2](/filings/0000007789-25-000179.md) | [4.4](/filings/0000007789-25-000179.md) | [4.6](/filings/0000007789-26-000260.md) | [4.7](/filings/0000007789-26-000260.md) | [4.8](/filings/0000007789-26-000260.md) | [4.9](/filings/0000007789-26-000260.md) | [5.0](/filings/0000007789-26-000260.md) | [5.0](/filings/0000007789-26-000260.md) | [5.6](/filings/0000007789-26-000260.md) | [5.5](/filings/0000007789-26-000260.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [64.6 d](/filings/0000007789-26-000071.md) | [155](/filings/0000007789-25-000049.md) | [113 d](/filings/0000007789-25-000116.md) | [105 d](/filings/0000007789-25-000179.md) | [207 d](/filings/0000007789-26-000071.md) | [98.2](/filings/0000007789-26-000141.md) | [141 d](/filings/0000007789-26-000202.md) | [158 d](/filings/0000007789-26-000260.md) | [218 d](/filings/0000007789-26-000071.md) | [136](/filings/0000007789-26-000141.md) | [207 d](/filings/0000007789-26-000202.md) | [329 d](/filings/0000007789-26-000260.md) |
| Dividends paid | $m | [33.5 d](/filings/0000007789-26-000071.md) | [33.5](/filings/0000007789-25-000049.md) | [33.5 d](/filings/0000007789-25-000116.md) | [33.6 d](/filings/0000007789-25-000179.md) | [38.6 d](/filings/0000007789-26-000071.md) | [38.5](/filings/0000007789-26-000141.md) | [38.5 d](/filings/0000007789-26-000202.md) | [38.5 d](/filings/0000007789-26-000260.md) | [40.2 d](/filings/0000007789-26-000071.md) | [40.1](/filings/0000007789-26-000141.md) | [45.7 d](/filings/0000007789-26-000202.md) | [45.2 d](/filings/0000007789-26-000260.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [151](/filings/0000007789-24-000043.md) | [151](/filings/0000007789-24-000062.md) | [151](/filings/0000007789-24-000075.md) | [151](/filings/0000007789-25-000049.md) | [151](/filings/0000007789-25-000116.md) | [151](/filings/0000007789-25-000179.md) | [167](/filings/0000007789-26-000141.md) | [166](/filings/0000007789-26-000202.md) | [167](/filings/0000007789-26-000260.md) | [167](/filings/0000007789-26-000141.md) | [190](/filings/0000007789-26-000202.md) | [189](/filings/0000007789-26-000260.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 185,705,763 at 2026-10-23, from the cover of the [10-Q filed 2026-10-27](/filings/0000007789-26-000260.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 12:56 ET. No prices; not investment advice.